financetom
Business
financetom
/
Business
/
CVC sets IPO price at 14 euros per share, middle of range
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CVC sets IPO price at 14 euros per share, middle of range
Apr 25, 2024 11:38 PM

AMSTERDAM (Reuters) -CVC Capital Partners said on Friday it had set the final price for its initial public offering (IPO) at 14 euros ($15.02) per share, at the middle of its announced range.

The company had offered shares at a price range of 13 to 15 euros, with trading due to start on Euronext Amsterdam on Friday.

The company said it would raise 2-2.3 billion euros from the deal, depending on whether investors used their over-allotment options.

CVC's market value would be 14 billion euros.

The IPO in Amsterdam is likely to be one of Europe's biggest this year.

Europe has seen a string of companies go public recently, taking advantage of higher stock prices and improving investor sentiment.

Spanish beauty group Puig is scheduled to attempt an IPO in its home market in the coming days.

($1 = 0.9324 euros)

(Reporting by Tassilo Hummel, Bart Meijer and Emma-Victoria Farr, editing by Inti Landauro)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cellectar Shares Fall as Updated Data For Investigational Radiotherapy Shows Drop in Major Response Rate
Cellectar Shares Fall as Updated Data For Investigational Radiotherapy Shows Drop in Major Response Rate
Jul 23, 2024
01:26 PM EDT, 07/23/2024 (MT Newswires) -- Cellectar Biosciences ( CLRB ) shares were down nearly 19% in recent Tuesday trading after the company released updated data for its investigational radiotherapy Iopofosine I 131, showing a drop in major response rate. As of the May 31 cutoff, Iopofosine I 131 was found to have a major response rate of 56.4%...
Hospital Chain Operator HCA Healthcare Says Positive Q2 Earnings Reflect Strong Demand For Services, Issues Upbeat Annual Outlook
Hospital Chain Operator HCA Healthcare Says Positive Q2 Earnings Reflect Strong Demand For Services, Issues Upbeat Annual Outlook
Jul 23, 2024
On Tuesday, HCA Healthcare Inc. ( HCA ) reported second-quarter revenues of $17.49 billion, up from $15.86 billion a year ago and beating the consensus of $17.05 billion. The hospital chain reported adjusted EPS of $5.50, up from $4.29 a year ago, beating the consensus of $5.36. “The company’s results for the second quarter were positive and reflected strong demand for...
RTX's Raytheon Partners With Avio to Develop Solid Rocket Motors for Defense Applications
RTX's Raytheon Partners With Avio to Develop Solid Rocket Motors for Defense Applications
Jul 23, 2024
01:26 PM EDT, 07/23/2024 (MT Newswires) -- RTX (RTX) said Tuesday its Raytheon unit has signed a contract with Avio, a provider of propulsion technology, to develop solid rocket motors for defense applications. Financial details weren't disclosed. The contract advances the systems engineering efforts needed to refine solid rocket motors for production readiness, the company said. Price: 105.13, Change: +1.36,...
Why Transcode Therapeutics (RNAZ) Stock Is Down 60%
Why Transcode Therapeutics (RNAZ) Stock Is Down 60%
Jul 23, 2024
Transcode Therapeutics Inc ( RNAZ ) shares are trading lower by 62% to $0.30 during Tuesday’s session after the company announced pricing of its public offering. The public offering of 10 million shares of its common stock will be at $0.30 per share, aiming to raise $3 million before deducting expenses. The offering is set to close on July 24,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved